{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T23:01:24Z","timestamp":1791154884315,"version":"4.1.0"},"reference-count":0,"publisher":"Portico","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"DOI":"10.1358\/dnp.2010.23.4.1439500","type":"journal-article","created":{"date-parts":[[2010,6,3]],"date-time":"2010-06-03T05:24:16Z","timestamp":1275542656000},"page":"221","source":"Crossref","is-referenced-by-count":14,"title":["Immunotherapy for Epstein-Barr virus-associated malignancies"],"prefix":"10.3730","volume":"23","author":[{"family":"Long, H.M.","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"family":"Parsonage, G.","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"family":"Fox, C.P.","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"family":"Lee, S.P.","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1320","published-online":{"date-parts":[[2010]]},"container-title":["Drug News & Perspectives"],"original-title":[],"deposited":{"date-parts":[[2023,5,30]],"date-time":"2023-05-30T13:36:18Z","timestamp":1685453778000},"score":1,"resource":{"primary":{"URL":"http:\/\/access.portico.org\/stable?au=pjbf7k9r5n6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010]]},"references-count":0,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2010]]}},"URL":"https:\/\/doi.org\/10.1358\/dnp.2010.23.4.1439500","relation":{},"ISSN":["2013-0139"],"issn-type":[{"value":"2013-0139","type":"print"}],"subject":[],"published":{"date-parts":[[2010]]}}}